{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T09:02:33Z","timestamp":1790586153000,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Health & Medical Research Council (NHMRC) of Australia Senior Research Fellowship","award":["GNT10417660"],"award-info":[{"award-number":["GNT10417660"]}]},{"DOI":"10.13039\/100008792","name":"Novartis Pharma GmbH","doi-asserted-by":"crossref","award":["SFB699"],"award-info":[{"award-number":["SFB699"]}],"id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"crossref"}]},{"name":"U.S. Department of Veterans Affairs Merit Review","award":["BX000849"],"award-info":[{"award-number":["BX000849"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.mce.2019.01.015","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T13:13:09Z","timestamp":1547730789000},"page":"59-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"special_numbering":"C","title":["Relaxin and extracellular matrix remodeling: Mechanisms and signaling pathways"],"prefix":"10.1016","volume":"487","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2370-0849","authenticated-orcid":false,"given":"Hooi Hooi","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrishan S.","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Schlossmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2019.01.015_bib1","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1210\/endo.138.5.5147","article-title":"Relaxin counteracts asthma-like reaction induced by inhaled antigen in sensitized Guinea pigs","volume":"138","author":"Bani","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2019.01.015_bib2","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S1567-5769(02)00079-6","article-title":"Inhibitory effects of relaxin on human basophils activated by stimulation of the Fc epsilon receptor. The role of nitric oxide","volume":"2","author":"Bani","year":"2002","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.mce.2019.01.015_bib3","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ki.2010.516","article-title":"Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases","volume":"79","author":"Barnes","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.mce.2019.01.015_bib4","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1089\/ars.2005.7.1346","article-title":"Liver fibrogenesis: a new role for the renin-angiotensin system","volume":"7","author":"Bataller","year":"2005","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.mce.2019.01.015_bib5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1152\/physrev.00001.2012","article-title":"Relaxin family peptides and their receptors","volume":"93","author":"Bathgate","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.mce.2019.01.015_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijcard.2017.09.017","article-title":"Chronic lower-dose relaxin administration protects from arrhythmia in experimental myocardial infarction due to anti-inflammatory and anti-fibrotic properties","volume":"250","author":"Beiert","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.mce.2019.01.015_bib7","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.bbrc.2017.06.091","article-title":"Relaxin reduces susceptibility to post-infarct atrial fibrillation in mice due to anti-fibrotic and anti-inflammatory properties","volume":"490","author":"Beiert","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2019.01.015_bib8","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/liv.12247","article-title":"Relaxin decreases the severity of established hepatic fibrosis in mice","volume":"34","author":"Bennett","year":"2014","journal-title":"Liver Int."},{"key":"10.1016\/j.mce.2019.01.015_bib9","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0006-2952(03)00403-9","article-title":"Inhibition of markers of hepatic stellate cell activation by the hormone relaxin","volume":"66","author":"Bennett","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mce.2019.01.015_bib10","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1210\/endo-102-4-1292","article-title":"Relaxin-dependent adenosine 6',5'-monophosphate concentration changes in the mouse pubic symphysis","volume":"102","author":"Braddon","year":"1978","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2019.01.015_bib11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.regpep.2010.09.001","article-title":"Relaxin inhibits early steps in vascular inflammation","volume":"166","author":"Brecht","year":"2011","journal-title":"Regul. Pept."},{"key":"10.1016\/j.mce.2019.01.015_bib12","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1159\/000464125","article-title":"Anti-fibrosis effect of relaxin and spironolactone combined on isoprenaline-induced myocardial fibrosis in rats via inhibition of endothelial-mesenchymal transition","volume":"41","author":"Cai","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.mce.2019.01.015_bib13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jama.1958.02990040005002","article-title":"Use of relaxin in the treatment of scleroderma","volume":"166","author":"Casten","year":"1958","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.mce.2019.01.015_bib14","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/1440-1681.12798","article-title":"Opposite actions of urotensin II and relaxin-2 on cellular expression of fibronectin in renal fibrosis: a preliminary experimental study","volume":"44","author":"Cernaro","year":"2017","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.mce.2019.01.015_bib15","doi-asserted-by":"crossref","first-page":"21044","DOI":"10.18632\/oncotarget.15483","article-title":"Relaxin abrogates renal interstitial fibrosis by regulating macrophage polarization via inhibition of Toll-like receptor 4 signaling","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.mce.2019.01.015_bib16","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.biopha.2018.02.090","article-title":"Central role of dysregulation of TGF-beta\/Smad in CKD progression and potential targets of its treatment","volume":"101","author":"Chen","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mce.2019.01.015_bib17","doi-asserted-by":"crossref","first-page":"e42714","DOI":"10.1371\/journal.pone.0042714","article-title":"Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS","volume":"7","author":"Chow","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2019.01.015_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ki.2013.518","article-title":"Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis","volume":"86","author":"Chow","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.mce.2019.01.015_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.yjmcc.2013.10.019","article-title":"Myofibroblasts: trust your heart and let fate decide","volume":"70","author":"Davis","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.mce.2019.01.015_bib20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0008-6363(02)00663-6","article-title":"Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype","volume":"57","author":"Du","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.mce.2019.01.015_bib21","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/labinvest.2012.68","article-title":"Involvement of matrix metalloproteinase-2 in the development of renal interstitial fibrosis in mouse obstructive nephropathy","volume":"92","author":"Du","year":"2012","journal-title":"Lab. Invest."},{"key":"10.1016\/j.mce.2019.01.015_bib22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pharmthera.2017.11.004","article-title":"TGFbeta pathway inhibition in the treatment of non-small cell lung cancer","volume":"184","author":"Eser","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.mce.2019.01.015_bib23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1001\/archderm.1959.01560140012003","article-title":"Relaxin (releasin) therapy in diffuse progressive scleroderma; a preliminary report","volume":"79","author":"Evans","year":"1959","journal-title":"AMA Arch Derm"},{"key":"10.1016\/j.mce.2019.01.015_bib24","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/hep.26627","article-title":"Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertension in vivo","volume":"59","author":"Fallowfield","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.mce.2019.01.015_bib25","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1046\/j.1523-1755.2001.059003876.x","article-title":"Relaxin decreases renal interstitial fibrosis and slows progression of renal disease","volume":"59","author":"Garber","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.mce.2019.01.015_bib26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nri.2017.90","article-title":"Type 2 immunity in tissue repair and fibrosis","volume":"18","author":"Gieseck","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mce.2019.01.015_bib27","first-page":"111","article-title":"Tissue inhibitors of metalloproteinases: structure, regulation and biological functions","volume":"74","author":"Gomez","year":"1997","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.mce.2019.01.015_bib28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1124\/mol.105.021691","article-title":"Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanisms","volume":"70","author":"Halls","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.mce.2019.01.015_bib29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1523-1755.2005.00384.x","article-title":"The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway","volume":"68","author":"Heeg","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.mce.2019.01.015_bib30","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1210\/en.2010-0286","article-title":"Antifibrotic properties of relaxin: in vivo mechanism of action in experimental renal tubulointerstitial fibrosis","volume":"151","author":"Hewitson","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2019.01.015_bib31","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1210\/en.2006-0814","article-title":"Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fibrosis","volume":"148","author":"Hewitson","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2019.01.015_bib32","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1210\/en.2011-1311","article-title":"Relaxin and castration in male mice protect from, but testosterone exacerbates, age-related cardiac and renal fibrosis, whereas estrogens are an independent determinant of organ size","volume":"153","author":"Hewitson","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2019.01.015_bib33","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.ajpath.2012.02.004","article-title":"Recent developments in myofibroblast biology: paradigms for connective tissue remodeling","volume":"180","author":"Hinz","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mce.2019.01.015_bib34","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3181\/00379727-23-3107","article-title":"Experimental relaxation of the pubic ligament of the Guinea pig","volume":"23","author":"Hisaw","year":"1926","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.mce.2019.01.015_bib35","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1021\/bi1013968","article-title":"H3 relaxin demonstrates antifibrotic properties via the RXFP1 receptor","volume":"50","author":"Hossain","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.mce.2019.01.015_bib36","first-page":"RXFP1","article-title":"A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor","author":"Hossain","year":"2016","journal-title":"Chem. Sci."},{"key":"10.1016\/j.mce.2019.01.015_bib37","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1126\/science.1065654","article-title":"Activation of orphan receptors by the hormone relaxin","volume":"295","author":"Hsu","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.mce.2019.01.015_bib38","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.ajpath.2011.08.018","article-title":"Relaxin regulates myofibroblast contractility and protects against lung fibrosis","volume":"179","author":"Huang","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mce.2019.01.015_bib39","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1096\/fj.14-254789","article-title":"Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathy","volume":"29","author":"Huuskes","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.mce.2019.01.015_bib40","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3349\/ymj.2017.58.2.415","article-title":"Relaxin modulates the expression of MMPs and TIMPs in fibroblasts of patients with carpal tunnel syndrome","volume":"58","author":"Kang","year":"2017","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.mce.2019.01.015_bib41","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.canlet.2016.03.033","article-title":"TGF-beta signaling in liver and gastrointestinal cancers","volume":"379","author":"Katz","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mce.2019.01.015_bib42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3181\/0707-MR-190","article-title":"Mechanisms of fibrogenesis","volume":"233","author":"Kisseleva","year":"2008","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.mce.2019.01.015_bib43","doi-asserted-by":"crossref","first-page":"F861","DOI":"10.1152\/ajprenal.00362.2001","article-title":"Obstructive nephropathy and renal fibrosis","volume":"283","author":"Klahr","year":"2002","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.mce.2019.01.015_bib44","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1038\/s41598-017-02916-5","article-title":"ML290 is a biased allosteric agonist at the relaxin receptor RXFP1","volume":"7","author":"Kocan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mce.2019.01.015_bib45","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1161\/CIRCULATIONAHA.111.040352","article-title":"Epithelial-to-mesenchymal and endothelial-to-mesenchymal transition: from cardiovascular development to disease","volume":"125","author":"Kovacic","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2019.01.015_bib46","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1128\/MCB.24.2.687-696.2004","article-title":"Impaired nipple development and parturition in LGR7 knockout mice","volume":"24","author":"Krajnc-Franken","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.mce.2019.01.015_bib47","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nm.3218","article-title":"Origin and function of myofibroblasts in kidney fibrosis","volume":"19","author":"LeBleu","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.mce.2019.01.015_bib48","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1038\/ki.2010.418","article-title":"Mechanistic connection between inflammation and fibrosis","author":"Lee","year":"2010","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.mce.2019.01.015_bib49","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2133.2011.10439.x","article-title":"Adenovirus-relaxin gene therapy for keloids: implication for reversing pathological fibrosis","volume":"165","author":"Lee","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.mce.2019.01.015_bib50","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.HYP.0000171930.00697.2f","article-title":"Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats","volume":"46","author":"Lekgabe","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2019.01.015_bib51","doi-asserted-by":"crossref","first-page":"e0190935","DOI":"10.1371\/journal.pone.0190935","article-title":"Relaxin reverses inflammatory and immune signals in aged hearts","volume":"13","author":"Martin","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2019.01.015_bib52","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008441","article-title":"Relaxin family member insulin-like peptide 6 ameliorates cardiac fibrosis and prevents cardiac remodeling in murine heart failure models","volume":"7","author":"Maruyama","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.mce.2019.01.015_bib53","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1210\/endo.138.11.5520","article-title":"Relaxin counteracts myocardial damage induced by ischemia-reperfusion in isolated Guinea pig hearts: evidence for an involvement of nitric oxide","volume":"138","author":"Masini","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2019.01.015_bib54","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1172\/JCI117549","article-title":"Effects of Relaxin on Mast Cells: in vitro and in vivo studies in rats and Guinea pigs","volume":"94","author":"Masini","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2019.01.015_bib55","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/ndt\/gfg598","article-title":"Relaxin down-regulates renal fibroblast function and promotes matrix remodelling in vitro","volume":"19","author":"Masterson","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.mce.2019.01.015_bib56","doi-asserted-by":"crossref","first-page":"10806","DOI":"10.1038\/s41598-017-10521-9","article-title":"In search of a small molecule agonist of the relaxin receptor RXFP1 for the treatment of liver fibrosis","volume":"7","author":"McBride","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mce.2019.01.015_bib57","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-beta: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.mce.2019.01.015_bib58","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1096\/fj.08-120857","article-title":"Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2","volume":"23","author":"Mookerjee","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.mce.2019.01.015_bib59","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","article-title":"Matrix metalloproteinases","volume":"274","author":"Nagase","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2019.01.015_bib60","doi-asserted-by":"crossref","first-page":"10663","DOI":"10.1073\/pnas.92.23.10663","article-title":"The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer","volume":"92","author":"Nakajima","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2019.01.015_bib61","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1096\/fj.03-0216fje","article-title":"Relaxin inhibits lipopolysaccharide-induced adhesion of neutrophils to coronary endothelial cells by a nitric oxide-mediated mechanism","volume":"17","author":"Nistri","year":"2003","journal-title":"FASEB J."},{"issue":"Suppl. 1","key":"10.1016\/j.mce.2019.01.015_bib62","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1007\/s00011-007-0602-6","article-title":"Mast cell inhibition and reduced ventricular arrhythmias in a swine model of acute myocardial infarction upon therapeutic administration of relaxin","volume":"57","author":"Nistri","year":"2008","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.mce.2019.01.015_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082185","article-title":"Real-time imaging reveals augmentation of glutamate-induced Ca(2+) transients by the NO-cGMP pathway in cerebellar granule neurons","volume":"19","author":"Paolillo","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mce.2019.01.015_bib64","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1124\/jpet.116.232215","article-title":"Protection from cigarette smoke-induced lung dysfunction and damage by H2 relaxin (serelaxin)","volume":"357","author":"Pini","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.mce.2019.01.015_bib65","series-title":"RXFP1, 6th Modern Solid Phase Peptide Synthesis & its Applications Symposium. Queensland, Australia","first-page":"55","article-title":"A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor","author":"Praveen","year":"2017"},{"key":"10.1016\/j.mce.2019.01.015_bib66","first-page":"609","article-title":"Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia\/reperfusion injury via eNOS-dependent mechanism","volume":"113","author":"Raleigh","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.mce.2019.01.015_bib67","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.scr.2015.09.007","article-title":"Mesenchymal stem cells and serelaxin synergistically abrogate established airway fibrosis in an experimental model of chronic allergic airways disease","volume":"15","author":"Royce","year":"2015","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.mce.2019.01.015_bib68","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/labinvest.2010.198","article-title":"Relaxin remodels fibrotic healing following myocardial infarction","volume":"91","author":"Samuel","year":"2011","journal-title":"Lab. Invest."},{"key":"10.1016\/j.mce.2019.01.015_bib69","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1210\/en.2008-1062","article-title":"Relaxin family peptide receptor-1 protects against airway fibrosis during homeostasis but not against fibrosis associated with chronic allergic airways disease","volume":"150","author":"Samuel","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2019.01.015_bib70","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/bph.13529","article-title":"Anti-fibrotic actions of relaxin","volume":"174","author":"Samuel","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.mce.2019.01.015_bib71","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1210\/en.2004-0209","article-title":"Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo","volume":"145","author":"Samuel","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2019.01.015_bib72","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1096\/fj.02-0449fje","article-title":"Relaxin deficiency in mice is associated with an age-related progression of pulmonary fibrosis","volume":"17","author":"Samuel","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.mce.2019.01.015_bib73","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1196\/annals.1282.025","article-title":"The relaxin gene-knockout mouse: a model of progressive fibrosis","volume":"1041","author":"Samuel","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.mce.2019.01.015_bib74","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1111\/j.1523-1755.2004.00628.x","article-title":"Relaxin-1-deficient mice develop an age-related progression of renal fibrosis","volume":"65","author":"Samuel","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.mce.2019.01.015_bib75","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/bph.12964","article-title":"Serelaxin-mediated signal transduction in human vascular cells: bell-shaped concentration-response curves reflect differential coupling to G proteins","volume":"172","author":"Sarwar","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.mce.2019.01.015_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063896","article-title":"Relaxin Prevents Cardiac Fibroblast-Myofibroblast Transition via Notch-1-Mediated Inhibition of TGF-\u00ce2\/Smad3 Signaling","volume":"8","author":"Sassoli","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2019.01.015_bib77","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/2211-5463.12202","article-title":"Inhibition of the TGFbeta signalling pathway by cGMP and cGMP-dependent kinase I in renal fibrosis","volume":"7","author":"Schinner","year":"2017","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.mce.2019.01.015_bib78","doi-asserted-by":"crossref","first-page":"871","DOI":"10.7326\/0003-4819-132-11-200006060-00004","article-title":"Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial","volume":"132","author":"Seibold","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.mce.2019.01.015_bib79","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1357-2725(02)00271-6","article-title":"Inflammation and angiotensin II","volume":"35","author":"Suzuki","year":"2003","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.mce.2019.01.015_bib80","doi-asserted-by":"crossref","first-page":"10681","DOI":"10.1016\/S0021-9258(18)87000-4","article-title":"Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts","volume":"265","author":"Unemori","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2019.01.015_bib81","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1172\/JCI119099","article-title":"Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo","volume":"98","author":"Unemori","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2019.01.015_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.432","article-title":"Real-time examination of cAMP activity at relaxin family peptide receptors using a BRET-based biosensor","volume":"6","author":"Valkovic","year":"2018","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.mce.2019.01.015_bib83","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/cvr\/cvu062","article-title":"Crosstalk between fibroblasts and inflammatory cells","volume":"102","author":"Van Linthout","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.mce.2019.01.015_bib84","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fphar.2016.00091","article-title":"The anti-fibrotic actions of relaxin are mediated through a NO-sGC-cGMP-Dependent pathway in renal myofibroblasts in vitro and enhanced by the NO donor, diethylamine NONOate","volume":"7","author":"Wang","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.mce.2019.01.015_bib85","doi-asserted-by":"crossref","first-page":"9793","DOI":"10.1038\/s41598-017-09470-0","article-title":"Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"issue":"Suppl. 1","key":"10.1016\/j.mce.2019.01.015_bib86","first-page":"107","article-title":"Myocardial fibrosis: role of angiotensin II and aldosterone","volume":"88","author":"Weber","year":"1993","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.mce.2019.01.015_bib87","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00210-017-1394-z","article-title":"Differences in the renal antifibrotic cGMP\/cGKI-dependent signaling of serelaxin, zaprinast, and their combination","volume":"390","author":"Wetzl","year":"2017","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.mce.2019.01.015_bib88","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fphar.2016.00195","article-title":"Involvement of cyclic guanosine monophosphate-dependent protein kinase I in renal antifibrotic effects of serelaxin","volume":"7","author":"Wetzl","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.mce.2019.01.015_bib89","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/gut.49.4.577","article-title":"Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo","volume":"49","author":"Williams","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.mce.2019.01.015_bib90","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.mce.2019.01.015_bib91","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1097\/HJH.0b013e3283532099","article-title":"Angiotensin II AT(2) receptor decreases AT(1) receptor expression and function via nitric oxide\/cGMP\/Sp1 in renal proximal tubule cells from Wistar-Kyoto rats","volume":"30","author":"Yang","year":"2012","journal-title":"J. Hypertens."},{"key":"10.1016\/j.mce.2019.01.015_bib92","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000365852","article-title":"Protective effects of relaxin against cisplatin-induced nephrotoxicity in rats","volume":"128","author":"Yoshida","year":"2014","journal-title":"Nephron Exp. Nephrol."},{"key":"10.1016\/j.mce.2019.01.015_bib93","first-page":"F1169","article-title":"Relaxin protects against renal ischemia-reperfusion injury","volume":"305","author":"Yoshida","year":"2013","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.mce.2019.01.015_bib94","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.diabres.2017.08.018","article-title":"Transforming growth factor beta (TGF-beta) mediates cardiac fibrosis and induces diabetic cardiomyopathy","volume":"133","author":"Yue","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.mce.2019.01.015_bib95","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm1613","article-title":"Endothelial-to-mesenchymal transition contributes to cardiac fibrosis","volume":"13","author":"Zeisberg","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.mce.2019.01.015_bib96","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/jcmm.13464","article-title":"H3 relaxin inhibits the collagen synthesis via ROS- and P2X7R-mediated NLRP3 inflammasome activation in cardiac fibroblasts under high glucose","volume":"22","author":"Zhang","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.mce.2019.01.015_bib97","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00441-017-2662-4","article-title":"Alterations of relaxin and its receptor system components in experimental diabetic cardiomyopathy rats","volume":"370","author":"Zhang","year":"2017","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.mce.2019.01.015_bib98","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1095\/biolreprod63.3.697","article-title":"Collagen studies in late pregnant relaxin null mice","volume":"63","author":"Zhao","year":"2000","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.mce.2019.01.015_bib99","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1248\/bpb.b16-00882","article-title":"Relaxin ameliorates renal fibrosis and expression of endothelial cell transition markers in rats of isoproterenol-induced heart failure","volume":"40","author":"Zheng","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.mce.2019.01.015_bib100","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.2147\/DDDT.S85399","article-title":"Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway","volume":"9","author":"Zhou","year":"2015","journal-title":"Drug Des. Dev. Ther."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720719300218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720719300218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:07:04Z","timestamp":1759586824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720719300218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":100,"alternative-id":["S0303720719300218"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2019.01.015","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relaxin and extracellular matrix remodeling: Mechanisms and signaling pathways","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2019.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}